DANAHER CORP (DAP.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:DAP - US2358511028 - Common Stock
DAP.DE Key Statistics, Chart & Performance
The current stock price of DAP.DE is 192.62 EUR. In the past month the price decreased by -1.77%. In the past year, price decreased by -12.6%.
DAP.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DIM.PA | SARTORIUS STEDIM BIOTECH | 47.4 | 19.88B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 47.26 | 19.83B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 52.65 | 17.98B | ||
| SRT.DE | SARTORIUS AG | 40.83 | 13.94B | ||
| QIA.DE | QIAGEN N.V. | 19.18 | 8.40B | ||
| 1SXP.MI | SCHOTT PHARMA AG& CO KGAA | 16.74 | 2.45B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 15.28 | 2.23B | ||
| EVT.DE | EVOTEC SE | N/A | 1.84B | ||
| GXI.DE | GERRESHEIMER AG | 7.31 | 931.20M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.7 | 210.01M | ||
| MLC.I | MALIN CORP PLC | N/A | 33.34M |
Related stock screener links
About DAP.DE
Company Profile
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Company Info
DANAHER CORP
2200 Pennsylvania Ave NW Ste 800W
WASHINGTON WASHINGTON DC US
Employees: 62000
Phone: 12028280850
DANAHER CORP / DAP.DE FAQ
Can you describe the business of DANAHER CORP?
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Can you provide the latest stock price for DANAHER CORP?
The current stock price of DAP.DE is 192.62 EUR. The price increased by 0.32% in the last trading session.
What is the dividend status of DANAHER CORP?
DANAHER CORP (DAP.DE) has a dividend yield of 0.57%. The yearly dividend amount is currently 0.9.
How is the ChartMill rating for DANAHER CORP?
DAP.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists DAP stock?
DAP.DE stock is listed on the Frankfurt Stock Exchange exchange.
Should I buy DAP stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DAP.DE.
Can you provide the ownership details for DAP stock?
You can find the ownership structure of DANAHER CORP (DAP.DE) on the Ownership tab.
DAP.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to DAP.DE. When comparing the yearly performance of all stocks, DAP.DE turns out to be only a medium performer in the overall market: it outperformed 44.24% of all stocks.
DAP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DAP.DE. DAP.DE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
DAP.DE Financial Highlights
Over the last trailing twelve months DAP.DE reported a non-GAAP Earnings per Share(EPS) of 6.58. The EPS increased by 3.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.43% | ||
| ROA | 4.38% | ||
| ROE | 6.86% | ||
| Debt/Equity | 0.33 |
DAP.DE Forecast & Estimates
29 analysts have analysed DAP.DE and the average price target is 223.44 EUR. This implies a price increase of 16% is expected in the next year compared to the current price of 192.62.
For the next year, analysts expect an EPS growth of 4.05% and a revenue growth 3.11% for DAP.DE